(BKD) Brookdale Senior Living - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1124631045
Independent Living, Assisted Living, Memory Care, CCRC
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 45.8% |
| Value at Risk 5%th | 60.7% |
| Relative Tail Risk | -19.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.63 |
| Alpha | 71.47 |
| CAGR/Max DD | 1.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.372 |
| Beta | 0.880 |
| Beta Downside | 0.730 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.55% |
| Mean DD | 12.15% |
| Median DD | 9.71% |
Description: BKD Brookdale Senior Living November 13, 2025
Brookdale Senior Living Inc. (BKD) operates a nationwide portfolio of senior-living communities across three core segments: Independent Living for middle-to-upper-income retirees, Assisted Living & Memory Care that provides 24-hour support and dementia-focused services, and Continuing Care Retirement Communities (CCRCs) that combine independent, assisted, memory-care and skilled-nursing options under one roof or via management contracts. The company both owns and leases properties, and it also offers third-party management services.
Key operational metrics that analysts watch include an FY 2023 occupancy rate of roughly 84% across its independent-living portfolio and an average monthly rent (ADR) of about $3,200, which together generated $2.4 billion in revenue. Demographically, the U.S. is adding ~10,000 baby-boomers to the 65-plus cohort each month, supporting long-term demand, while inflation-driven labor costs and tighter Medicare/Medicaid reimbursement rules remain material headwinds for profitability.
For a deeper dive into BKD’s valuation sensitivities and how its cash-flow profile stacks up against sector peers, you might find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-306.7m TTM) > 0 and > 6% of Revenue (6% = 187.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 2.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.23% (prev -3.73%; Δ 0.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 228.7m > Net Income -306.7m (YES >=105%, WARN >=100%) |
| Net Debt (5.24b) to EBITDA (441.3m) ratio: 11.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (234.3m) change vs 12m ago 2.72% (target <= -2.0% for YES) |
| Gross Margin 27.20% (prev 27.21%; Δ -0.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.17% (prev 49.75%; Δ 2.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.21 (EBITDA TTM 441.3m / Interest Expense TTM 306.0m) >= 6 (WARN >= 3) |
Altman Z'' -3.09
| (A) -0.02 = (Total Current Assets 536.9m - Total Current Liabilities 637.8m) / Total Assets 6.01b |
| (B) -0.71 = Retained Earnings (Balance) -4.26b / Total Assets 6.01b |
| (C) 0.01 = EBIT TTM 65.4m / Avg Total Assets 5.98b |
| (D) -0.71 = Book Value of Equity -4.26b / Total Liabilities 6.02b |
| Total Rating: -3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.39
| 1. Piotroski 2.0pt |
| 2. FCF Yield 1.06% |
| 3. FCF Margin 2.63% |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 11.88 |
| 6. ROIC - WACC (= -2.90)% |
| 7. RoE -267.9% |
| 8. Rev. Trend 90.64% |
| 9. EPS Trend 40.77% |
What is the price of BKD shares?
As of December 14, 2025, the stock is trading at USD 10.27 with a total of 2,160,087 shares traded.
Over the past week, the price has changed by -4.73%, over one month by -2.28%, over three months by +36.75% and over the past year by +94.88%.
Over the past week, the price has changed by -4.73%, over one month by -2.28%, over three months by +36.75% and over the past year by +94.88%.
Is BKD a buy, sell or hold?
Brookdale Senior Living has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold BKD.
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the BKD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.4 | 11.4% |
| Analysts Target Price | 11.4 | 11.4% |
| ValueRay Target Price | 13.2 | 28.1% |
BKD Fundamental Data Overview December 06, 2025
Market Cap USD = 2.53b (2.53b USD * 1.0 USD.USD)
P/E Forward = 47.619
P/S = 0.8203
P/B = 18.976
P/EG = -0.75
Beta = 0.684
Revenue TTM = 3.12b USD
EBIT TTM = 65.4m USD
EBITDA TTM = 441.3m USD
Long Term Debt = 4.16b USD (from longTermDebt, last quarter)
Short Term Debt = 186.4m USD (from shortTermDebt, last quarter)
Debt = 5.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 7.77b USD (2.53b + Debt 5.50b - CCE 253.4m)
Interest Coverage Ratio = 0.21 (Ebit TTM 65.4m / Interest Expense TTM 306.0m)
FCF Yield = 1.06% (FCF TTM 82.1m / Enterprise Value 7.77b)
FCF Margin = 2.63% (FCF TTM 82.1m / Revenue TTM 3.12b)
Net Margin = -9.84% (Net Income TTM -306.7m / Revenue TTM 3.12b)
Gross Margin = 27.20% ((Revenue TTM 3.12b - Cost of Revenue TTM 2.27b) / Revenue TTM)
Gross Margin QoQ = 27.36% (prev 26.56%)
Tobins Q-Ratio = 1.29 (Enterprise Value 7.77b / Total Assets 6.01b)
Interest Expense / Debt = 2.18% (Interest Expense 119.7m / Debt 5.50b)
Taxrate = -0.15% (negative due to tax credits) (167.0k / -114.6m)
NOPAT = 65.5m (EBIT 65.4m * (1 - -0.15%)) [negative tax rate / tax credits]
Current Ratio = 0.84 (Total Current Assets 536.9m / Total Current Liabilities 637.8m)
Debt / Equity = -816.7 (out of range, set to none) (Debt 5.50b / totalStockholderEquity, last quarter -6.73m)
Debt / EBITDA = 11.88 (Net Debt 5.24b / EBITDA 441.3m)
Debt / FCF = 63.88 (Net Debt 5.24b / FCF TTM 82.1m)
Total Stockholder Equity = 114.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.10% (Net Income -306.7m / Total Assets 6.01b)
RoE = -267.9% (Net Income TTM -306.7m / Total Stockholder Equity 114.5m)
RoCE = 1.53% (EBIT 65.4m / Capital Employed (Equity 114.5m + L.T.Debt 4.16b))
RoIC = 1.51% (NOPAT 65.5m / Invested Capital 4.35b)
WACC = 4.41% (E(2.53b)/V(8.03b) * Re(9.26%) + D(5.50b)/V(8.03b) * Rd(2.18%) * (1-Tc(-0.00)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.95%
[DCF Debug] Terminal Value 65.15% ; FCFE base≈82.1m ; Y1≈53.9m ; Y5≈24.6m
Fair Price DCF = 1.68 (DCF Value 399.7m / Shares Outstanding 237.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 40.77 | EPS CAGR: 34.08% | SUE: -0.23 | # QB: 0
Revenue Correlation: 90.64 | Revenue CAGR: 6.75% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=N/A | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.55 | Chg30d=+0.015 | Revisions Net=+0 | Growth EPS=+50.9% | Growth Revenue=-5.1%
P/E Forward = 47.619
P/S = 0.8203
P/B = 18.976
P/EG = -0.75
Beta = 0.684
Revenue TTM = 3.12b USD
EBIT TTM = 65.4m USD
EBITDA TTM = 441.3m USD
Long Term Debt = 4.16b USD (from longTermDebt, last quarter)
Short Term Debt = 186.4m USD (from shortTermDebt, last quarter)
Debt = 5.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 7.77b USD (2.53b + Debt 5.50b - CCE 253.4m)
Interest Coverage Ratio = 0.21 (Ebit TTM 65.4m / Interest Expense TTM 306.0m)
FCF Yield = 1.06% (FCF TTM 82.1m / Enterprise Value 7.77b)
FCF Margin = 2.63% (FCF TTM 82.1m / Revenue TTM 3.12b)
Net Margin = -9.84% (Net Income TTM -306.7m / Revenue TTM 3.12b)
Gross Margin = 27.20% ((Revenue TTM 3.12b - Cost of Revenue TTM 2.27b) / Revenue TTM)
Gross Margin QoQ = 27.36% (prev 26.56%)
Tobins Q-Ratio = 1.29 (Enterprise Value 7.77b / Total Assets 6.01b)
Interest Expense / Debt = 2.18% (Interest Expense 119.7m / Debt 5.50b)
Taxrate = -0.15% (negative due to tax credits) (167.0k / -114.6m)
NOPAT = 65.5m (EBIT 65.4m * (1 - -0.15%)) [negative tax rate / tax credits]
Current Ratio = 0.84 (Total Current Assets 536.9m / Total Current Liabilities 637.8m)
Debt / Equity = -816.7 (out of range, set to none) (Debt 5.50b / totalStockholderEquity, last quarter -6.73m)
Debt / EBITDA = 11.88 (Net Debt 5.24b / EBITDA 441.3m)
Debt / FCF = 63.88 (Net Debt 5.24b / FCF TTM 82.1m)
Total Stockholder Equity = 114.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.10% (Net Income -306.7m / Total Assets 6.01b)
RoE = -267.9% (Net Income TTM -306.7m / Total Stockholder Equity 114.5m)
RoCE = 1.53% (EBIT 65.4m / Capital Employed (Equity 114.5m + L.T.Debt 4.16b))
RoIC = 1.51% (NOPAT 65.5m / Invested Capital 4.35b)
WACC = 4.41% (E(2.53b)/V(8.03b) * Re(9.26%) + D(5.50b)/V(8.03b) * Rd(2.18%) * (1-Tc(-0.00)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.95%
[DCF Debug] Terminal Value 65.15% ; FCFE base≈82.1m ; Y1≈53.9m ; Y5≈24.6m
Fair Price DCF = 1.68 (DCF Value 399.7m / Shares Outstanding 237.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 40.77 | EPS CAGR: 34.08% | SUE: -0.23 | # QB: 0
Revenue Correlation: 90.64 | Revenue CAGR: 6.75% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=N/A | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.55 | Chg30d=+0.015 | Revisions Net=+0 | Growth EPS=+50.9% | Growth Revenue=-5.1%
Additional Sources for BKD Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle